Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions

 

View research grants awarded by year.
Robert Tranquillo, PhD
The project aims to develop and test a novel method to create replacement blood vessels that are rapidly seeded with cells derived from a simple…
2022-2024
Juan Carlos Rivera-Mulia, PhD
1. Construct integrative models that characterize the developmental states and rhythms of early embryogenesis. 2. Identify the developmental…
2022-2024
Rory Smoot, MD
This application examines the mechanisms by which targeting the molecule YAP with medications can facilitate liver regeneration. We propose that YAP…
2022-2024
Joseph Metzger, PhD
This proposal focuses on leveraging advances in cardiac stem cell biology to forge new therapeutic modalities for combating heart disease, the…
2022-2024
Qiuying Liu, PhD
Congenital hydrocephalus is a major cause of childhood morbidity. Mutations in Trim71, a conserved stem-cell-specific RNA-binding protein, cause this…
2022-2024
James Dutton, PhD
Dry Age related macular degeneration is a chronic disease of aging that causes progressive loss of vision due to damage to the RPE cell layer in the…
2022-2024
Aaron Krych, MD
The overall goal of this study is to test the safety and feasibility for a one-stage cartilage restoration procedure for symptomatic defects of the…
2022-2024
Elizabeth Siegler, PhD
Mesenchymal stromal cells (MSCs) have intrinsic immunosuppressive and regenerative properties. We seek to engineer MSCs with artificial receptors to…
2021-2023
Enis Kostallari, PhD
Public Health Relevance: Alcoholic Hepatitis (AH) is a severe liver disease and is a leading cause of morbidity and mortality in the United States of…
2021-2023
Matthew Abdel, MD
Joint stiffening (arthrofibrosis) is a debilitating complication with limited treatment options that is observed in a substantial subset of patients…
2021-2023
Isobel Scarisbrick, PhD
Our goal is to develop a new treatment strategy that improves outcomes in individuals with chronic spinal cord injury. Studies will contribute to the…
2021-2023
Brenda Ogle, PhD
The clinical prognosis for patients with hypertrophic cardiomyopathy (HCM) is very poor and the only long-term alternative is heart transplant. Our…
2021-2023